ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0967

Transcriptional Heterogeneity of Immune Cells in the Esophagus of Systemic Sclerosis Patients: A Comparison of Upper and Lower Esophageal Regions

Hadijat Makinde1, Miranda Gurra1, Salina Dominguez2, Matthew Dapas2, Tyler Therron2, Kathleen Aren3, Marie-Pier Tetreault2, Monique Hinchcliff4, Deborah Winter5 and Harris Perlman1, 1Northwestern University, Chicago, IL, 2Northwestern University, Chicago, 3Northwestern University Division of Rheumatology, Chicago, IL, 4Yale School of Medicine, Westport, CT, 5Northwestern University, Skokie, IL

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, immunology, innate immunity, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is characterized by an initial inflammatory phase followed by fibrosis. Esophageal dysfunction in SSc is associated with gastroesophageal reflux, leading to severe complications and contributing to fibrosis. Studies have shown that SSc patients exhibit increased numbers of specific immune cells, such as fibroblasts, and tissue macrophages, which correlate with disease severity and reduced survival. The role of immune cell populations in the different regions of the affected esophagus remains poorly understood. This study aims to investigate the transcriptional heterogeneity of immune cells in the esophagus of SSc patients, focusing on regional differences between the proximal and distal esophagus.

Methods: Esophageal biopsies were obtained from nine SSc patients, with cells divided into proximal and distal esophageal regions (a total of 15 samples). Single-cell RNA sequencing (scRNA-Seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-Seq) were performed on CD45+ immune cells isolated from dissociated tissue using fluorescence-activated cell sorting (FACS). Data were processed and analyzed using the 10x Genomics Cell Ranger 6.0.0 pipeline and the Seurat package. CITE-Seq was utilized to confirm the expression of specific cell-identifying markers.

Results: Analysis of the integrated immune cell data identified 19 individual clusters from about 30,000 cells, including T cells, B cells, and various myeloid cell subsets. Within the myeloid subsets (18% of CD45+), eight distinct clusters were identified, including multiple dendritic cell subsets (LAMP3+ ~5%) and macrophages. Notably, dendritic cells were more prevalent in the distal region compared to the proximal region. In contrast, T cells and B cells showed a higher ratio in the proximal region, with regulatory T (Treg) cells having the highest number of cells in the distal region. Cluster-specific analysis revealed differences in gene expression between the distal and proximal regions, characterized by differential expression of specific markers such as FABP4, CD11b, CD11c, CCR2, and APOE, as well as varying expression of HLA-antigens, indicating differences in antigen presentation capabilities.

Conclusion: This study is the first to evaluate immune cells in the esophagus of SSc patients with a focus on regional differences. We demonstrate the presence of diverse macrophage and other immune cell subsets within the esophagus of SSc patients, each potentially contributing to distinct functions and mechanisms in the pathogenesis of SSc. These findings underscore the importance of precisely identifying immune cell populations within affected organs and targeting specific subsets to effectively intervene in the inflammatory process of SSc. Future research will investigate the differential characteristics of these immune cell subsets between the proximal and distal esophagus.


Disclosures: H. Makinde: None; M. Gurra: None; S. Dominguez: None; M. Dapas: None; T. Therron: None; K. Aren: None; M. Tetreault: None; M. Hinchcliff: AbbVie/Abbott, 2, Boehringer Ingelheim, 5, Kadmon, 5; D. Winter: None; H. Perlman: Abbvie, 2, AnaptysBio, 12, Speaking, advising, consulting, or providing educational programs, Exagen, 2, Janssen, 2, Kiniksa, 2.

To cite this abstract in AMA style:

Makinde H, Gurra M, Dominguez S, Dapas M, Therron T, Aren K, Tetreault M, Hinchcliff M, Winter D, Perlman H. Transcriptional Heterogeneity of Immune Cells in the Esophagus of Systemic Sclerosis Patients: A Comparison of Upper and Lower Esophageal Regions [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/transcriptional-heterogeneity-of-immune-cells-in-the-esophagus-of-systemic-sclerosis-patients-a-comparison-of-upper-and-lower-esophageal-regions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptional-heterogeneity-of-immune-cells-in-the-esophagus-of-systemic-sclerosis-patients-a-comparison-of-upper-and-lower-esophageal-regions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology